공시 • Apr 29
Vimian Group AB (publ) to Report Fiscal Year 2026 Results on Feb 11, 2027 Vimian Group AB (publ) announced that they will report fiscal year 2026 results on Feb 11, 2027 공시 • Dec 24
Vimian Group AB (publ) (OM:VIMIAN) entered into an agreement to acquire I-Vet S.R.L. from the Franzini family. Vimian Group AB (publ) (OM:VIMIAN) entered into an agreement to acquire I-Vet S.R.L. from the Franzini family on December 23, 2025. The acquisition is financed with available funds. Following the acquisition, I-Vet will be integrated into Vimian’s Diagnostics segment, and CEO Daniele Franzini will continue to lead I-Vet as part of Vimian.
For the period ending December 31, 2024, I-Vet S.R.L. reported total revenue of €5.6 million and has 75 team members.
The acquisition is expected to be completed on or around March 2, 2026. The acquisition is expected to have marginal impact on earnings per share in the 2026 financial year. 공시 • Oct 20
Vimian Group AB (publ) to Report Fiscal Year 2025 Final Results on Mar 19, 2026 Vimian Group AB (publ) announced that they will report fiscal year 2025 final results on Mar 19, 2026 공시 • Sep 23
Vimian Group AB (publ), Annual General Meeting, Apr 29, 2026 Vimian Group AB (publ), Annual General Meeting, Apr 29, 2026. 공시 • Jun 13
Vimian Group AB (publ) (OM:VIMIAN) signed an agreement to acquire AllAccem Inc. Vimian Group AB (publ) (OM:VIMIAN) signed an agreement to acquire AllAccem Inc. on June 13, 2025. AllAccem Inc. had revenues of around $9 million for the twelve months ending April 2025, and an EBITDA margin significantly above the Vimian Group average. AllAccem will become part of Vimian’s MedTech segment and Jeffery Whiteford, founder and CEO of AllAccem Inc., will continue to lead the integrated business. The acquisition is expected to have marginal impact on earnings per share in the current financial year. The acquisition of AllAccem Inc. is expected to be completed on or around 13 June and is financed with available funds. 공시 • Apr 30
Vimian Group AB (publ) Elects Pia Marions as Board Member Vimian Group AB (publ) at its Annual General Meeting held on 29 April 2025, Pia Marions was newly elected, as Board members for the time until the end of the next Annual General Meeting. 공시 • Mar 14
Vimian Group AB (publ) to Report Q4, 2025 Results on Feb 12, 2026 Vimian Group AB (publ) announced that they will report Q4, 2025 results on Feb 12, 2026 공시 • Oct 12
Vimian Group AB (publ), Annual General Meeting, Apr 29, 2025 Vimian Group AB (publ), Annual General Meeting, Apr 29, 2025. 공시 • May 23
Vimian Group AB (publ) Elects Magnus Welander to Board as Chairman of the Board Vimian Group AB (publ) at its Annual General Meeting held on 22 May 2024 announced that Magnus Welander was newly elected, as Board members for the time until the end of the next Annual General Meeting. Magnus Welander was elected as chairman of the Board. 공시 • Apr 05
Vimian Group AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 1.632566 billion. Vimian Group AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 1.632566 billion.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 65,302,624
Price\Range: SEK 25
Transaction Features: Regulation S; Rights Offering 공시 • Dec 22
Vimian Group AB (publ) Announces CEO Changes Vimian Group AB (publ) appoints Patrik Eriksson Chief Executive Officer, effective 1 January 2024. Patrik Eriksson joins Vimian from Envista, a global dental company listed on NYSE, where he currently serves on the Executive Team as President of Nobel Biocare. Patrik Eriksson (56) has vast international experience from 25 years as general manager in the global medtech and life science industries. Since 2020, he is President of the dental company Nobel Biocare, part of Envista. Prior to that, he worked seven years at the global life sciences group Danaher (NYSE:DHR) as President of two of its medtech companies, KavoKerr and Ormco. He has led international organizations with more than 6,500 employees and revenues of USD 1.5 billion. He is a Swedish citizen and holds a M.Sc. in Business and Administration from the Stockholm School of Economics. Patrik Eriksson succeeds Fredrik Ullman whose departure at year-end was announced on 29 June 2023. 공시 • Sep 26
Fidelio Capital acquired a 12% stake in Vimian Group AB (publ) for approximately SEK 240 million. Fidelio Capital acquired a 12% stake in Vimian Group AB (publ) for approximately SEK 240 million on September 21, 2023.
Fidelio Capital completed the acquisition of a 12% stake in Vimian Group AB (publ) on September 21, 2023. 공시 • Jun 30
Vimian Group AB (publ) Announces Fredrik Ullman Step Down as CEO Vimian Group AB (publ) announced that CEO Fredrik Ullman, following consultation with the Board, steps down as CEO. Fredrik Ullman has been the CEO of Vimian since its inception in 2020 and the CEO of its subsidiary Indical Bioscience since 2018. The recruitment process for a new CEO will be initiated immediately with Fredrik Ullman remaining as CEO in the interim and at the latest until year-end. The recruitment process for a new CEO will be initiated immediately and Fredrik Ullman will remain as CEO in the interim. 공시 • Jun 03
Vimian Group AB (Publ) Elects Robert Belkic as New Board Member Vimian Group AB (publ) at the Annual General Meeting 2 June 2023, announced Robert Belkic was newly elected, as Board members for the time until the end of the next Annual General Meeting. 공시 • Oct 25
Vimian Group AB (publ), Annual General Meeting, Jun 01, 2023 Vimian Group AB (publ), Annual General Meeting, Jun 01, 2023. 
